All articles tagged with #us competition
Shares of Novo Nordisk fell over 6% due to concerns about ongoing US competition from copycat drugs, a profit warning, and the appointment of a new CEO aimed at improving US market performance, leading to a $70 billion loss in market value.
Novo Nordisk's shares plummeted over 22% after the company issued a profit warning due to intense US market competition and slower-than-expected sales growth for its weight-loss drugs Ozempic and Wegovy, leading to a significant reduction in its full-year sales and profit forecasts, amid ongoing legal actions against copycat drugs.
China has become a global leader in biotech, surpassing the U.S. in clinical trials and innovation, driven by government strategy, lower costs, and new treatments, prompting concerns in the U.S. about maintaining its industry dominance.